MedPath

Chordia Therapeutics, Inc.

Chordia Therapeutics, Inc. logo
🇯🇵Japan
Ownership
Public
Established
2017-01-01
Employees
21
Market Cap
-
Website
http://www.chordiatherapeutics.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Phase 1
Recruiting
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Interventions
First Posted Date
2023-02-16
Last Posted Date
2024-08-23
Lead Sponsor
Chordia Therapeutics, Inc.
Target Recruit Count
170
Registration Number
NCT05732103
Locations
🇺🇸

Mayo Clinic Arizona, Phoenix, Arizona, United States

🇺🇸

Mayo Clinic Florida, Jacksonville, Florida, United States

🇺🇸

Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.